Zimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma

NCT05688215 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

56

Enrollment

OTHER

Sponsor class

Conditions

Borderline Resectable Pancreatic Adenocarcinoma
Locally Advanced Pancreatic Ductal Adenocarcinoma

Interventions

PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
PROCEDURE: Core Biopsy
DRUG: Fluorouracil
DRUG: Irinotecan
DRUG: Leucovorin
DRUG: Leucovorin Calcium
DRUG: Oxaliplatin
DRUG: Quemliclustat
DRUG: Zimberelimab

Sponsor

Jonsson Comprehensive Cancer Center

Collaborators

[object Object]